The PBM industry just made our point – New Jersey Globe ¤

In a recent turn of events, lawmakers in New Jersey have intensified their scrutiny of Pharmacy Benefit Managers (PBMs), reigniting a long-standing debate about the role these intermediaries play in the healthcare system. A new report from the PBM industry, which advocates for greater transparency and efficiency, has inadvertently underscored the very issues that state senators have raised regarding pricing and access to medications. As these legislative discussions unfold, the implications for patients, pharmacies, and the broader healthcare landscape become increasingly significant. In this article, we explore the key arguments presented by state officials, the responses from the PBM sector, and what it means for New Jersey residents grappling with rising prescription costs.

Senators Respond to PBM Industry Impact on Healthcare Costs

In a recent series of hearings, senators voiced strong concerns about the growing influence of Pharmacy Benefit Managers (PBMs) on…